OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the endocannabinoid system in diabesity: Fact or fiction?
Farah Deeba, Ashish Kumar, Monalisa Mukherjee, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1750-1758
Closed Access | Times Cited: 14
Farah Deeba, Ashish Kumar, Monalisa Mukherjee, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 7, pp. 1750-1758
Closed Access | Times Cited: 14
Showing 14 citing articles:
Amelioration of endothelial integrity by 3,5,4′-trihydroxy-trans-stilbene against high-fat-diet-induced obesity and -associated vasculopathy and myocardial infarction in rats, targeting TLR4/MyD88/NF-κB/iNOS signaling cascade
Jitender Singh, Priyanka Bisht, Srishti Srivastav, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 705, pp. 149756-149756
Closed Access | Times Cited: 5
Jitender Singh, Priyanka Bisht, Srishti Srivastav, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 705, pp. 149756-149756
Closed Access | Times Cited: 5
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Endocannabinoid-Binding Receptors as Drug Targets
María Gómez‐Cañas, Carmen Rodríguez‐Cueto, Valentina Satta, et al.
Methods in molecular biology (2022), pp. 67-94
Closed Access | Times Cited: 14
María Gómez‐Cañas, Carmen Rodríguez‐Cueto, Valentina Satta, et al.
Methods in molecular biology (2022), pp. 67-94
Closed Access | Times Cited: 14
Dysbiosis versus diabesity: Pathological signaling and promising therapeutic strategies
Arun Kumar Sharma, Akash Sharma, Samridhi Lal, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103558-103558
Closed Access | Times Cited: 7
Arun Kumar Sharma, Akash Sharma, Samridhi Lal, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 5, pp. 103558-103558
Closed Access | Times Cited: 7
Preliminary investigation on impact of intergenerational treatment of resveratrol endorses the development of ‘super-pups’
Arun Kumar Sharma, Monalisa Mukherjee, Ashish Kumar, et al.
Life Sciences (2022) Vol. 314, pp. 121322-121322
Closed Access | Times Cited: 10
Arun Kumar Sharma, Monalisa Mukherjee, Ashish Kumar, et al.
Life Sciences (2022) Vol. 314, pp. 121322-121322
Closed Access | Times Cited: 10
Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1667-1667
Open Access | Times Cited: 4
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1667-1667
Open Access | Times Cited: 4
Novel cannabinoid receptor 1 inverse agonist CRB ‐913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the diet‐induced obesity mouse model
Marshall Morningstar, Andrew Kolodziej, Suzie A. Ferreira, et al.
Obesity (2023) Vol. 31, Iss. 11, pp. 2676-2688
Open Access | Times Cited: 4
Marshall Morningstar, Andrew Kolodziej, Suzie A. Ferreira, et al.
Obesity (2023) Vol. 31, Iss. 11, pp. 2676-2688
Open Access | Times Cited: 4
Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
Krzysztof Mińczuk, Marta Baranowska‐Kuczko, Anna Krzyżewska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6350-6350
Open Access | Times Cited: 7
Krzysztof Mińczuk, Marta Baranowska‐Kuczko, Anna Krzyżewska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6350-6350
Open Access | Times Cited: 7
Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets
Fatemeh Aghamahdi, Arman Shafiee, Sayeh Rostami, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 5, pp. 102499-102499
Open Access | Times Cited: 4
Fatemeh Aghamahdi, Arman Shafiee, Sayeh Rostami, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 5, pp. 102499-102499
Open Access | Times Cited: 4
Synthesis, molecular docking, and pharmacological evaluation of 5-(4-(2-(5-ethyl pyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2, 4-dione against HFD-induced diabesity via interaction with the CB1 receptor.
Farah Deeba, Mohammad Shahar Yar, Mohammad Rafi Haidar, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 25, Iss. 8, pp. 1028-1036
Closed Access | Times Cited: 4
Farah Deeba, Mohammad Shahar Yar, Mohammad Rafi Haidar, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 25, Iss. 8, pp. 1028-1036
Closed Access | Times Cited: 4
Molecular basis of phytochemical–gut microbiota interactions
Samridhi Lal, Md Sayeed Akhtar, Mohd Faiyaz Khan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103824-103824
Closed Access | Times Cited: 2
Samridhi Lal, Md Sayeed Akhtar, Mohd Faiyaz Khan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103824-103824
Closed Access | Times Cited: 2
Identification of Different Extracts and Phytoconstituents of Callistemon Viminalis Cheel for Their Anti-Anxiety Effects Based on Pharmacognostic, Toxicological, and Pharmacological Strategies
N. Kumari, Arun Mittal, Arpana Rana, et al.
Toxicology Reports (2024) Vol. 13, pp. 101726-101726
Open Access
N. Kumari, Arun Mittal, Arpana Rana, et al.
Toxicology Reports (2024) Vol. 13, pp. 101726-101726
Open Access
THE NEWEST THERAPEUTICALLY APPROACH OF “DIABESITY” USING GLP-1 RA MOLECULES: IMPACT OF THE ORAL FORMULATION
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 1, pp. 1-10
Open Access | Times Cited: 1
Mariana Cornelia Tilinca
FARMACIA (2023) Vol. 71, Iss. 1, pp. 1-10
Open Access | Times Cited: 1
Mariana Cornelia Tilinca, Csilla Antal, Alina Balint, et al.
FARMACIA (2023) Vol. 71, Iss. 1
Open Access
